Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Circulating Tumor Cell”

684 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 684 results

Not applicableLooking for participantsNCT05623956
What this trial is testing

Proteomics in Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Aalborg University Hospital 50
Not applicableActive Not RecruitingNCT04574635
What this trial is testing

Human Papilloma Virus (HPV) Circulating Tumor DNA (ctDNA) in Cervical Cancer

Who this might be right for
Cervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma, Not Otherwise SpecifiedInfiltrating Cervical Carcinoma+24 more
Mayo Clinic 18
Not applicableStudy completedNCT01173458
What this trial is testing

Circulating Tumor Cells (CTCs) as a Blood-based Tumor Marker in Patients With Small Cell Lung Cancer (SCLC)

Who this might be right for
Small Cell Lung Cancer
University of Kansas Medical Center 25
Not applicableNot Yet RecruitingNCT07060950
What this trial is testing

Analysis of Circulating Tumor Markers in Blood - ALCINA 5

Who this might be right for
CancerLung Cancer, Non-Small Cell
Institut du Cancer de Montpellier - Val d'Aurelle 620
Testing effectiveness (Phase 2)Looking for participantsNCT05420948
What this trial is testing

Pembrolizumab in Combination With Chemotherapy for Head and Neck Cancer

Who this might be right for
Head and Neck CancerHead and Neck Squamous Cell CarcinomaHead and Neck Neoplasms+2 more
University of Chicago 30
Not applicableLooking for participantsNCT06154668
What this trial is testing

Profiling of Circulating Immune Cells to Uncover Response Signatures to Anti-PD1 Immunotherapy in Melanoma Patients

Who this might be right for
Melanoma
University Hospital, Grenoble 707
Testing effectiveness (Phase 2)Looking for participantsNCT06070012
What this trial is testing

Tebentafusp in HLA-A*0201 Positive Previously Untreated Metastatic Uveal Melanoma

Who this might be right for
Uveal Melanoma
Diwakar Davar 44
Not applicableStudy completedNCT04083547
What this trial is testing

Circulating Tumour Cells in Patients With Peritoneal Metastases

Who this might be right for
Circulating Tumor CellPeritoneal MetastasesHyperthermic Intraperitoneal Chemotherapy
Uppsala University 114
Not applicableStudy completedNCT01713699
What this trial is testing

Circulating Tumor Cells and Cytology in Cerebrospinal Fluid of Patients Clinically Suspected for Leptomeningeal Metastases

Who this might be right for
Meningeal Carcinomatosis
The Netherlands Cancer Institute 146
Not applicableStudy completedNCT02974764
What this trial is testing

Changes in Biomarkers From Blood Over Time in Patients With Pancreatic Adenocarcinoma

Who this might be right for
Neoplastic Cells, CirculatingPancreatic CancerBiological Markers
Johns Hopkins University 200
Not applicableUnknownNCT03381326
What this trial is testing

CTC, Free DNA, Stem Cells and EMT-related Antigens as Biomarkers of Activity of Cabazitaxel in CRPC.

Who this might be right for
Prostate CancerMetastatic CancerCastration-resistant Prostate Cancer+1 more
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 104
Not applicableActive Not RecruitingNCT06808113
What this trial is testing

Circulating and Molecular Markers Involved in the Processes of Cachexia, Anorexia and Sarcopenia in Patients With NSCLC

Who this might be right for
Non Small Cell Lung Cancer
IRCCS Azienda Ospedaliero-Universitaria di Bologna 40
Not applicableStudy completedNCT00001148
What this trial is testing

Detecting Malignant Brain Tumor Cells in the Bloodstream During Surgery to Remove the Tumor

Who this might be right for
AstrocytomaGlioblastomaGlioma
National Institute of Neurological Disorders and Stroke (NINDS) 25
Testing effectiveness (Phase 2)Ended earlyNCT01126879
What this trial is testing

Genistein in Treating Patients With Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage I Prostate Cancer+2 more
Northwestern University 12
Not applicableUnknownNCT02940977
What this trial is testing

Establishment and Clinical Assessment of a Prostate Cancer (PCa) Risk Model Based on the Updated Circulating Tumor Cell (CTC) Detection Technique

Who this might be right for
Prostatic NeoplasmsProstatic Adenoma
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 120
Not applicableStudy completedNCT02372448
What this trial is testing

Multicenter Validation of the Sensitivity of Theranostic ALK Rearrangement Detection by FISH Analysis and Prevalence of Escaping Mutations in Circulating Tumor Cells for the Non-invasive Management of Lung Cancer Patients

Who this might be right for
Lung Neoplasms
Centre Hospitalier Universitaire de Nice 206
Not applicableLooking for participantsNCT06717243
What this trial is testing

Genomic and Methylation Markers in SCLC and LCNEC for Chemo-Immunotherapy Resistance Prediction (STRATUS)

Who this might be right for
Small Cell Lung CancerLarge Cell Neuroendocrine (NE) TumorsTreatment Failure+3 more
Oncology Center of Biochemical Education And Research 111
Testing effectiveness (Phase 2)UnknownNCT04239443
What this trial is testing

Clinical Study of PD-1 Monoclonal Antibody SHR-1210 and Apatinib in Advanced NSCLC, Soft Tissue Sarcoma, and Uterine Cancer

Who this might be right for
Advanced Non Small Cell Lung CancerUterine CancerSoft Tissue Sarcoma
Hunan Cancer Hospital 120
Not applicableStudy completedNCT04763148
What this trial is testing

Tumor Heterogeneity in Diffuse Large B-cell Lymphoma in Relation to CNS Involvement and Cell-free DNA

Who this might be right for
Lymphoma, Large B-Cell, Diffuse
Herlev Hospital 26
Not applicableActive Not RecruitingNCT06744075
What this trial is testing

Study of the Clearance of Minimal Residual Disease Measured at the End of First-line Treatment in Patients With Lymphoma

Who this might be right for
B-cell LymphomaHodgkin Lymphoma
Centre Henri Becquerel 108
Load More Results